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ABSTRACT
Objective The objective of this study was to explore the attitudes of obstetricians in Australia, New Zealand and the
UK towards prenatally diagnosed trisomy 18 (T18).
Method Obstetricians were contacted by email and invited to participate in an anonymous electronic survey.
Results Survey responses were obtained from 1018/3717 (27%) practicing obstetricians/gynaecologists. Most (60%)
had managed a case of T18 in the last 2 years. Eighty-ﬁve per cent believed that T18 was a ‘lethal malformation’,
although 38% expected at least half of liveborn infants to survive for more than 1week. Twenty-one per cent indicated
that a vegetative existence was the best developmental outcome for surviving children. In a case of antenatally
diagnosed T18, 95% of obstetricians would provide a mother with the option of termination. If requested, 99% would
provide maternal-focused obstetric care (aimed at maternal wellbeing rather than fetal survival), whereas 80% would
provide fetal-oriented obstetric care (to maximise fetal survival). Twenty-eight per cent would never discuss the
option of caesarean; 21% would always discuss this option. Management options, attitudes and knowledge of T18
were associated with location, practice type, gender and religion of obstetricians.
Conclusion There is variability in obstetricians’ attitudes towards T18, with signiﬁcant implications for management
of affected pregnancies. © 2013 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
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INTRODUCTION
Trisomy 18 (T18) is one of the commonest major chromosomal
abnormalities,1 affecting about 1/4000 live births.2 There appears
to be a rising incidence due to increasingmaternal age as well as
the inﬂuence of early aneuploidy screening (with recognition of
T18 in some fetuses who miscarry).3 However, birth prevalence
remains steady because of termination of pregnancy following
antenatal diagnosis.3,4
In the last decade, there has been a shift in attitude of
paediatricians towards T18.5,6 This follows publication of
evidence that despite a high rate of fetal or neonatal death, a
small proportion of affected infants are able to survive infancy.
This has been coupled with increasing parental requests for
active treatment.5,6 Long-term survival is associated with
severe to profound developmental disabilities.7,8 The majority
of fetuses and infants with T18 have cardiac defects, although
these range in severity.9 Cardiac surgery is offered in some
parts of the world10,11 but not in others. This raises challenging
ethical questions about management of affected fetuses
and infants.8,12
A number of guidelines have been written about obstetric
management following diagnosis of severe malformations such
as T18. There are strong recommendations that counselling
about termination should be non-directive13,14 and should
avoid the term ‘lethal’.15 If a pregnancy continues, it has been
recommended that women are offered the option of
maternal-focused obstetric management (aimed at maternal
wellbeing rather than fetal survival).16,17 However, ethicists
and commentators have argued that it is also appropriate for
women to be given the option of fetal-oriented care (aimed at
maximising fetal survival), for example including fetal monitoring
during labour and/or caesarean section (CS).17,18
Recent accounts by women who have experienced antenatal
diagnosis of T18 have described a relative lack of support once
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they expressed a desire not to terminate their pregnancy.19–21
Parent narratives commonly describe a desire for live birth if
possible, with varying degrees of postnatal intervention. It is
not known how obstetricians respond to requests for fetal-
oriented obstetric care.
A recent paper examined the attitudes of US obstetricians
towards management options for severe fetal malformations
(for example T18).22 There are no available data on the
knowledge or attitudes of obstetricians in Australia, New
Zealand or the UK. We sought to explore the attitudes of
doctors working in these countries to prenatal, intrapartum
and postpartum care when a pregnancy is affected by T18.
METHODS
Fellows of the Royal Australian and New Zealand College of
Obstetrics and Gynaecology (RANZCOG) and fellows and
members of the Royal College of Obstetrics and Gynaecology
(RCOG) in the UK were contacted by email and invited to
participate in an anonymous electronic survey. Non-respondents
were sent two reminder emails.
The survey had been developed by the study authors after a
review of the medical literature. It was validated and modiﬁed
following pilot surveys with practising obstetricians. The
survey included basic demographic questions (gender, practice
type, years of experience and religion) and questions about
experience, knowledge and attitudes towards T18. Questions
about religion were based on the British Social Attitudes
survey.23 At the request of RANZCOG, Australian and New
Zealand (A/NZ) participants were not asked about their
religious beliefs. For attitudes towards T18, respondents were
asked their level of agreement on six-point Likert scales.
Participants were presented with a hypothetical case of a
woman whose pregnancy was diagnosed with T18 at 13weeks
and were asked about treatment options they would discuss
or offer following diagnosis. In the event that the woman’s
pregnancy continued, participants were asked about further
management provided during pregnancy and around the time
of delivery. Participants were speciﬁcally asked how they
would respond to a request by the patient for either maternally
focused or fetally oriented obstetric care using questions
derived from a recent US survey.22
Statistical analysis was carried out using SAS software, version 9.3
(SAS Institute Inc, Cary, NC, USA). The ﬁndings were descriptively
presented as frequency (%) for discrete variables and mean
(standard deviation) or median (inter-quartile range), where
appropriate, for continuous variables. The association between
baseline characteristics and outcomes of interest were explored
using the Pearson chi-square test for independence or Fisher’s
exact test, where appropriate, for discrete variables, and Student’s
T test orMann–WhitneyU test, where appropriate, for continuous
variables. We performed logistic regression models to determine
the independent effect of baseline characteristics including
location (UK vs Australia), gender (female vs male), years of
practising as a specialist, main practice (obstetrics, ultrasound or
maternal–fetal medicine vs other) and main practice location
(tertiary vs other) on the following outcomes: expectation of
survival or development for T18, discussion or provision of
termination of pregnancy, andmaternal or fetal-oriented obstetric
management. (Religion was excluded from the multivariate
analysis as this information was only available for UK
respondents.) For Likert scale responses, ‘strongly agree’ and
‘moderately agree’ were grouped together, as were ‘strongly
disagree’ and ‘moderately disagree’. A p-value of 0.05 or less was
considered to indicate statistical signiﬁcance.
RESULTS
Sample
We wrote to 3820 obstetricians/gynaecologists by email. There
were 1121 replies, of whom 103 indicated that they were not
usually involved in the care of pregnant women and were
excluded. We analysed 1018 responses from practising
obstetricians, including 436 responses from A/NZ (47% of
those contacted) and 582 from UK (20% of those contacted).
Table 1 indicates baseline demographic information for
respondents in A/NZ and UK. Because UK senior trainees are
members of the RCOG, whereas RANZCOG Fellowship is only
awarded on completion of training, there were more trainees
in the UK cohort, there being none in the A/NZ cohort.
Personal experience
Sixty per cent of respondents indicated that they had been
involved in managing a case of antenatally diagnosed T18 in the
last 2years, and 8% had never managed a case of T18; 37% of
respondents had managed at least ﬁve cases. Most respondents
(70%) indicated a high rate (≥95%) of termination of pregnancy
in cases with which they had been personally involved.
Attitudes and expectations
A high proportion (85%) of respondents moderately or strongly
agreed with a statement that T18 was a ‘lethal malformation’
(Table 2), although 38% indicated that from their experience
and understanding at least half of liveborn infants would
survive for more than 1week with treatment. Seventy-one per
cent of respondents expected 5-20% of infants to survive for
more than 1 year, whereas 78% indicated that profound
disability or a vegetative existence was the best developmental
outcome for surviving children.
Management
Ninety-two per cent of participants indicated that they would
always discuss or offer termination following antenatal diagnosis
of T18 (Table 3). Twenty-one per cent (201) of respondents
indicated that they had an ethical or moral objection to
termination; 84% (174) of those with an objection would refer to
another obstetrician who would offer termination.
In the event of a continuing pregnancy, 99% of respondents
would comply with a request for maternal-focused obstetric
care, with 28% encouraging this request. Eighty per cent of
respondents would comply with a request for fetal-oriented
obstetric care in the same situation, although 37% would
discourage this approach. Twenty-three per cent of respondents
would never discuss or offer fetal monitoring in labour, whereas
24%would always offer this option. Twenty-eight per cent would
never offer CS in the event of fetal distress, whereas 21% would
always discuss this option.
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Inﬂuence of location
There were signiﬁcant differences between respondents from
the UK and A/NZ in baseline characteristics (Table 1). A higher
proportion of UK respondents were female, in training or
worked in district/general hospitals. Australian respondents
were more likely to have >25 years of experience, to work
predominantly in private practice and in obstetrics.
Management of pregnancies following diagnosis of T18 also
differed by location (Table 3 and Table S1). A higher proportion
of A/NZ respondents would always or sometimes offer
termination and pastoral care in the event of a continuing
pregnancy. Respondents from the UK were more likely to
discuss or offer paediatric consultation, palliative care,
multidisciplinary team involvement, fetal monitoring and CS.
Similar proportions of respondents would comply with
requests for eithermaternal-oriented or fetal-oriented obstetric
care. Respondents from the UK had more recent experience of
T18 and reported a lower proportion of pregnancies followed
by termination. Attitudes towards T18, and expectations of
outcome were similar (data not shown).
Gender
There was a higher proportion of female respondents from the
UK (60% vs 42%, p< 0.0001). Women were more likely to have
5–15 years of practise as a specialist (44% vs 26%, p< 0.0001);
Table 1 Baseline characteristics of participants by location
Characteristics Overall, n (%) Australia, n (%) UK, n (%) p-valuea
Gender (n=920)b
Male 440 (47.8) 236 (58.0) 204 (39.8) <0.0001
Female 480 (52.2) 171 (42.0) 309 (60.2)
Years practising as a specialist (n=932)b
Still in training 52 (5.6) 0 52 (10.0) <0.0001
<5 years 143 (15.3) 60 (14.6) 83 (16.0)
5–15 years 330 (35.4) 141 (34.2) 189 (36.4)
15–25 years 254 (27.3) 107 (26.0) 147 (28.3)
>25 years 153 (16.4) 104 (25.2) 49 (9.4)
Main practice (n=1015)b
Obstetrics 619 (61.0) 294 (67.7) 325 (55.9) <0.0001
Gynaecology 214 (21.0) 75 (17.3) 139 (23.9)
Maternal–fetal medicine 140 (13.8) 43 (9.9) 97 (16.7)
Ultrasound/prenatal testing 29 (2.9) 19 (4.4) 10 (1.7)
Others 13 (1.3) 3 (0.7) 10 (1.7)
Main practice location (n=1015)b
Tertiary hospital 336 (33.1) 144 (33.2) 192 (33.1) <0.0001
District general/regional public hospital 509 (50.1) 134 (30.9) 375 (64.5)
Private hospital 73 (7.2) 69 (15.9) 4 (0.7)
Private practice 89 (8.8) 84 (19.4) 5 (0.9)
Other 8 (0.8) 3 (0.7) 5 (0.9)
Religionc (n=514)b





Strength of religionc (n=515)b
Religious 275 (53.4) N/A
Non-religious 101 (19.6)
Neither religious nor non-religious 139 (27.0)
aChi-squared test or Fisher’s exact test where appropriate, comparing responses by location.
bn refers to the number of participants responding to that question (participants did not always answer every question).
cQuestions about religion were only asked of participants from the UK.
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they had managed similar numbers of cases recently, but a
smaller proportion of female respondents indicated that all
past cases had been followed by termination (35% vs 47%,
p= 0.002). Female respondents were more likely to comply
with a request for maternal-focused obstetric care (100% vs
97%, p = 0.004), but a similar proportion would comply with
a request for fetal-oriented care. A similar proportion of male
and female respondents were directive in counselling,
actively encouraging or discouraging management options.
A higher proportion of female obstetricians would discuss or
offer paediatric consultation (72% vs 63%), palliative care
(92% vs 81%), multidisciplinary team input (83% vs 73%),
clinical ethics consultation (49% vs 38%) and pastoral care
(67% vs 53%, p< 0.0001). A smaller proportion of female
respondents expected that the majority of liveborn
infants with T18 would survive for more than 12months
(3% vs 8%, p = 0.002).
Religion
Amongst UK respondents, the strength of religious views
appeared to inﬂuence management options. Fifty-three per
cent (275) of respondents indicated that they were
somewhat, very or extremely religious, whereas 20% (101)
were somewhat, very or extremely non-religious, and 27%
(139) were neither religious nor non-religious (neutral).
Those who described themselves as religious were more
likely to express an ethical or moral objection to termina-
tion (32%) than those who were non-religious (3%) or neutral
(12%, p< 0.0001). Eighty-four per cent of religious respon-
dents would always discuss termination following antenatal
diagnosis of T18 compared with 97% of non-religious and
89% of those who were neutral (p = 0.007). Eight per cent
of religious or neutral respondents would only discuss
termination if asked or would never discuss it compared with
1% of non-religious respondents (Table S2). Of those
respondents who expressed an objection to termination,
89% of religious respondents would refer to another practition-
er for termination compared with 100% of non-religious
respondents (p=NS).
Speciﬁc religious denominations were associated with
attitudes to termination. Those who would not offer
termination (compared with those who would discuss/offer
Table 2 Attitudes towards T18, and expectations of outcome
Attitudes towards T18 (n=962)a Strongly/moderately disagree, n (%) Strongly/moderately agree, n (%)
T18 is a lethal abnormality 72 (7.5) 813 (84.5)
A fetus with T18 should be treated no differently from any other fetus 721 (75.0) 110 (11.4)
Active treatment of a fetus or newborn with T18 is futile 163 (16.9) 601 (62.5)
T18 is compatible with the child having a meaningful life 759 (78.9) 79 (8.2)
T18 is incompatible with life 274 (28.5) 521 (54.2)
Infants with T18 should not be resuscitated at birth (n=948)a 269 (28.4) 421 (44.4)
Knowledge/expectations about outcome for fetuses with T18 (n=936)a Expected outcome (proportion of fetuses or
newborns that respondent would expect
to achieve speciﬁed outcome)
Proportion of respondents, n (%)












Best developmental outcome if survives for some time (non-mosaic) Mild intellectual disability 34 (3.6)
Severe disability 170 (18.2)
Profound disabilityb 540 (57.7)
Vegetative existence 192 (20.5)
an refers to the total number of respondents who answered an individual question (participants did not always answer every question).
bEstimate of outcome that appears most consistent with population-based ﬁgures – see discussion.
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termination) were more likely to indicate that their religious
afﬁliation was Muslim (44% vs 12%) and less likely to be
Christian (33% vs 43%) or no religion (6% vs 20%, p< 0.0001).
Non-religious respondents were more likely to strongly or
moderately agree that infants with T18 should not be
resuscitated at birth (57%) than religious (32%) or neutral (38%)
respondents (p< 0.0001). Religious respondents were more
likely to indicate that fetuses with T18 should be treated no
differently from any other fetus and more likely to discuss or
offer clinical ethics consultation. They had similar expectations
about outcome for fetuses and infants with T18 to non-religious
respondents (data not shown). The speciﬁc religion of respondents
Table 3 Treatment options for T18 discussed or offered following antenatal diagnosis
Options/responses Overall, n (%) A/NZ, n (%) UK, n (%) p-valuea
Main management options (n=962)b
Termination of pregnancy
Always/sometimes 912 (94.8)c 408 (96.9) 504 (93.2) 0.009
Only if asked/never 50 (5.2) 13 (3.1) 37 (6.8)
Paediatric consultation early in pregnancy
Always/sometimes 651 (67.7) 251 (59.6) 400 (73.9) <0.0001
Only if asked/never 311 (32.3) 170 (40.4) 141 (26.1)
Further management options if pregnancy continues (n=953)
If the pregnancy continues, and the woman asks you not to
intervene on the fetus’ behalf to maximise the chance
of a live birth (fetal monitoring/CS), would you comply?
(maternal-focused obstetric care)
939 (98.5) 410(98.1) 529 (98.9) 0.31
If yes, how would you counsel the patient?
Encourage 260 (27.8) 122 (29.8) 138 (26.2) 0.002
Support, but not encourage 390 (41.7) 147 (35.9) 243 (46.2)
Neither encourage nor discourage 255 (27.2) 120 (29.3) 135 (25.7)
Discourage 31 (3.3) 21 (5.1) 10 (1.9)
If the pregnancy continues, and the woman asks you to
intervene on the fetus’ behalf to maximise the chance
of a live birth (fetal monitoring, CS), would you comply?
(fetal-oriented obstetric care)
755 (79.5) 335 (80.1) 420 (79.0) 0.65
If yes, how would you counsel the patient?
Encourage 22 (2.9) 13 (3.89) 9 (2.1) 0.34
Support, not encourage 269 (35.6) 116 (34.6) 153 (36.4)
Neither encourage nor discourage 182 (24.1) 75 (22.4) 107 (25.5)
Discourage 282 (37.4) 131 (39.1) 151 (36.0)
Palliative care-based perinatal management
Always/sometimes 826 (86.7) 344 (82.3) 482 (90.1) <0.0001
Only if asked/never 127 (13.3) 74 (17.7) 53 (9.9)
Fetal monitoring during labour
Always/sometimes 363 (38.1) 124 (29.7) 239 (44.7) <0.0001
Only if asked/never 590 (61.9) 294 (70.3) 296 (55.3)
CS for fetal distress
Always/sometimes 309 (32.4) 115 (27.5) 194 (36.3) 0.004
Only if asked/never 644 (67.6) 303 (72.5) 341 (63.7)
Paediatrician present at birth
Routinely 618 (65.2) 250 (60.0) 368 (69.3) 0.009
If requested 311 (32.8) 156 (37.4) 155 (29.2)
Never 19 (2.0) 11 (2.6) 8 (1.5)
aChi-squared test comparing A/NZ responses with UK responses.
bn refers to the total number of respondents who answered an individual question (participants did not always answer every question).
c91.5% of respondents indicated that they would ‘always’ discuss or offer termination, and 3.3% would discuss termination ‘sometimes’.
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was not associated with provision of either maternal-focused or
fetal-oriented obstetric care.
Expectations of outcome
Respondents’ views about the outcome for fetuses and infants
with T18 were associated with management options that
would be provided on request. A higher proportion of
respondents who would not comply with a request for
maternal-focused obstetric care (compared with those who
would comply) expected a high chance (≥50%) of long-term
survival for infants (29% vs 5%, p< 0.0001). Respondents who
would comply with a request for obstetric care to maximise
fetal survival (compared with those who would not comply
with such a request) were more likely to believe that at least
half of infants with T18 survive for more than 1week (40% vs
26%) or 1 year (6% vs 2%) and that mild intellectual disability
(4% vs 1%) or severe disability (21% vs 9%) were the best
developmental outcomes (all p< 0.0001).
Factors inﬂuencing management options and expectations for
T18 (multivariate analysis)
Multivariate analysis indicated that physician location and type
of practice inﬂuenced whether respondents would discuss/offer
termination. UK respondents were less likely to discuss/offer
termination than A/NZ respondents (OR 0.43, p=0.02), whereas
those working in tertiary centres were more likely to discuss/
offer termination than those working in other settings (OR 3.5,
p=0.005). Female respondents were more likely to comply with
a request for maternal-focused obstetric management (OR 7.8,
p=0.009). Respondents with longer experience in practice were
more likely to indicate that a high proportion of fetuses with T18
survive to term (OR 1.8, p< 0.001), for more than 1week (OR 1.4,
p=0.02) and for more than 1year (OR 2.7, p=0.003); whereas
those with fetus-related specialities were less likely to indicate that
50% or more of fetuses with T18 survive for more than 1year (OR
0.5, p=0.02). There was no inﬂuence of experience or other
variables on expected developmental outcome.
DISCUSSION
This survey provides an insight into the views, knowledge and
experience of UK and A/NZ obstetricians about management
and counselling of antenatally diagnosed T18.
Our study provides valuable information about obstetricians’
understanding of outcome for T18. Just over half believed that
T18 was ‘incompatible with life’; more indicated that T18 was a
‘lethal’ anomaly. However, in an apparent contradiction, most
anticipated the possibility of long-term survival if treatment was
provided. The meaning of the term ‘lethal’ is potentially unclear
and is a source of confusion in the minds of women.15,20,24 We
have argued elsewhere that it should be avoided.15
Most respondents in the survey indicated correctly that
5–20% of fetuses would survive to full term if not terminated.
Recent studies have documented a high (87–88%) rate of
intrauterine death for fetuses with T18.1,25 In contrast, where
the diagnosis is made after 20weeks, a higher proportion
(~50%) of fetuses survive to live birth; this may reﬂect the
inﬂuence of placental mosaicism,26 as well as the fact that
fetuses with more severe structural abnormalities are likely to
have been diagnosed earlier.25,27,28
Obstetricians’ understanding of postnatal survival was
commonly incorrect. Most expected that less than a quarter of
liveborn T18 infants would survive for a week or more. In
population-based studies, the median survival for T18 is
approximately 6–10 days, with 43% surviving for more than
1week.29,30 Approximately 5–10% of infants survive for more
than 1 year.8,29 Furthermore, there are reports of 1-year survival
of 25% or more in cohorts of infants treated more actively
including cardiac surgery,10 raising the possibility that lower
survival ﬁgures may represent a ‘self-fulﬁlling prophecy’.31
There were variable views amongst obstetricians about the best
developmental outcome for surviving children with T18. Twenty
per cent expected a ‘vegetative’ existence, whereas 4% anticipated
only mild disability, views that do appear not to be supported by
the literature. Older children with full (non-mosaic) T18 have a
developmental age of about 6–8months overall but are able to
interact with their environment and with their family.7 They can
use a fewwords or signs and play independently. Families of these
children have expressed distress at overly negative information
given in counselling about long-term outcome.7,24 There may be
a role for further education to improve obstetricians’ knowledge
of potential outcome in T18.
Ninety-two per cent of surveyed obstetricians would always
discuss termination after ﬁrst trimester diagnosis of T18. This
compares with more than 99% of US obstetricians who would
discuss termination in a similar setting.22 In a separate
question, we asked whether respondents had an ethical or
moral objection to termination. Just over 20% of respondents
reported such an objection; however, many of these appeared
to distinguish between different reasons for termination.
Seventy-eight per cent of those with an objection would always
discuss termination following ﬁrst trimester diagnosis of T18.
Only nine respondents (<1%) indicated that they would never
discuss termination; seven indicated that although they had an
ethical objection to termination, they would refer a woman to
another obstetrician for this option. Twenty-nine respondents
(3%) indicated that they both objected to termination and would
not refer to another practitioner. Refusal to refer in the setting
of a conscientious objection conﬂicts with professional codes
of ethics32,33 and is potentially unlawful in England34,35 and in
one jurisdiction in Australia.36 We did not ask respondents to
identify their location and thus were not able to determine
the effect of this on practice. However, a small number noted
in free-text responses that they worked in Northern Ireland,
where access to termination has been extremely limited and
referral would not be legally required.37
Perhaps unsurprisingly, religious afﬁliation of obstetricians
was associated with attitudes towards termination. Those
who described themselves as religious were less likely to always
or usually discuss termination with women following a
diagnosis of T18. A recent paper from the USA found an
inﬂuence of obstetrician religion on views about directiveness
of counselling: Those who were non-religious and those with
theologically pluralistic views were more likely to refrain from
directive counselling.38 Our survey found the opposite: Non-
religious obstetricians had a higher proportion of directive
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responses, being more inclined (than ‘neutral’ or ‘religious’) to
actively encourage maternal-focused obstetric care and more
likely to discourage fetal-oriented care. The explanation for
these different ﬁndings is not immediately clear. It may relate
to population differences (USA vs UK). Alternatively, it may
relate to the type of case presented.
Following a diagnosis of T18, almost all respondents would
comply with a request for obstetric care focused on maternal
rather than fetal wellbeing, and 28% would actively encourage
this approach. A majority of obstetricians would also comply
with a woman’s request for obstetric care aimed at fetal survival,
although 20% would not comply with this request, and more
than 1/3 would actively discourage this option. These results
are very similar to those reported in a recent survey of US
obstetricians, where >99% would provide maternal-focused
obstetric care on request for a malformation such as T18, and
82% would provide fetal-oriented obstetric care if requested.22
In that survey, as in ours, only 1/4 of obstetricians indicated that
they would be non-directive, neither encouraging nor
discouraging maternal-oriented or fetal-oriented care.
We found that obstetricians were divided about speciﬁc
interventions such as fetal monitoring and CS. It is interesting that
roughly four in ﬁve respondents, independent of their country of
practice, would potentially offer fetal monitoring, CS and the
presence of a paediatrician at delivery in the context of a pregnancy
affected by T18. This is in contrast to the traditional view that it is
not appropriate tomonitor or intervenewhere a babyhas a severely
life-limiting prognosis.39,40 It may, however, reﬂect current practice
in some countries. In a study of live births in Texas from 1999 to
2005, 41% of infants with a prenatal diagnosis of T18 were
delivered by CS.41 In an Internet-based survey of families of
children with T18, half had been offered the option of CS.42
It would be interesting to ask practitioners why they sought
to inﬂuence women’s choice of obstetric management, in
particular, avoiding fetally oriented management. One
potential reason is harm to the woman. Obstetricians might
be concerned about imposing medical risks on the woman
(for example from CS) for relatively little beneﬁt to the fetus.
However, given the signiﬁcant value that some women place
on spending some time with a living child, this is a risk that
some women would be more than willing to take. A separate
concern might be that continuing a pregnancy or fetally
oriented management would harm the fetus. Yet even if such
infants survive for only a short period, or are profoundly
impaired, it is not clear that they are thereby harmed.43 Finally,
there might be concern about the long-term resource
implications of care for a child with T18.44 But although this
argument might justify limiting intensive care or cardiac
surgery for long-term survivors (although this is contested8,12),
the costs of future care are not usually thought to be sufﬁcient
grounds to justify limiting or inﬂuencing choices during
pregnancy. Such considerations would apply to a much
broader group of fetuses and would be arguably a form of
passive eugenics.45
Limitations of the study include the low response rate
(particularly from UK respondents), which may affect
generalisability. However, our overall results are consistent
with average response rates for electronic surveys in a recent
meta-analysis (34%).46 Although we were not able to ﬁnd data
on type of practice and location of practice in the wider UK/A/
NZ obstetrician population, the sex and duration of practice of
respondents were similar to the sex/age distribution in the
wider population of obstetricians in A/NZ and UK,47,48
reducing the likelihood of respondent bias (Table S3).49
In summary, there is signiﬁcant variability in UK and A/NZ
obstetricians’ knowledge of, attitudes towards and management
of prenatally diagnosed T18. One particularly important ﬁnding
is that directive counselling is still relatively common and that
some women may not be offered a full range of options for
management during pregnancy or at delivery. This suggests a
need for further debate within the professional community and
further practitioner education in order to provide consistent
and appropriate care for this uncommon but serious condition.
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WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• Many women choose to terminate after a prenatal diagnosis of
trisomy 18, although some continue their pregnancy.
• Professional and ethical guidelines indicate that obstetricians should
be non-directive in counselling and that fetal-oriented management
may be appropriate.
WHAT DOES THIS STUDY ADD?
• Obstetricians in the UK, Australia and New Zealand vary in their
management of prenatally diagnosed trisomy 18.
• Counselling is frequently directive.
• Perinatal management of trisomy 18 may be inﬂuenced by
practitioner values.
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